Atyr Pharma, Inc. · NASDAQ:ATYR

Schimmel Paul bought 100,000 Atyr Pharma, Inc. shares (Form 4)

Traded May 27, 2026 · Filed May 28, 2026

On May 27, 2026, Schimmel Paul (Director) bought 100,000 Atyr Pharma, Inc. shares at US$0.50 for US$50,000, leaving 779,143 shares. Filed May 28, 2026 (Form 4).

Bought
100,000 shares
Price
US$0.50
Value
US$50,000
Holding after
779,143 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockBuy100,000US$0.50779,143Indirect

Source

View original at SEC

Related